AI & Software Platforms

Encore celebrates its global 'Great Place To Work' award. We look past the press release to see if these certifications are just PR or a real driver of growth.

Amid data overload and budget cuts, Cision's new AI tool promises to decode media coverage into actionable strategy. But can it truly solve PR's dilemma?

Why does a vet visit cost so much? We dissect the complex factors driving prices, from diagnostics to overhead, and reveal how to manage your pet's health budget.

Artificial intelligence demands unprecedented, volatile power. Now, a new battle is on to define and build the 'AI-grade' infrastructure needed to fuel it.

The Canada Revenue Agency's 'Manage balance' service has processed $1.1B in debt, but does this digital shift truly help all Canadians?

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

SRx Health Solutions rebrands as SRX Global after acquiring a crypto AI firm. But with a history of pivots and a 35% stock drop, is this a brilliant rebirth or a desperate gamble?

New data reveals a 'Women CEO Effect'—companies led by women don't just break ceilings, they build entirely new pipelines for female leadership.

MorningBlues' new SonicGlass A1 isn't just a speaker; it's a transparent art piece that generates AI music videos. Is this the future of home audio?

Richtech Robotics' new 24/7 livestream isn't just a gimmick. It's a look at the digital backbone—from NVIDIA chips to AI grids—powering our future.

Spurred by national policy and landmark listings, Japan's innovators are looking to U.S. capital markets for global growth. A new summit maps the path.

GCL's deal for 'A Whisper of Fall: Jinyiwei' isn't just another game. It's a strategic move capitalizing on the global hunger for authentic Asian IP.

Aether Holdings launches Alphid, an AI platform connecting to brokerage accounts. Is this the key to leveling the playing field for retail investors, or a new risk?

A public company is offering a volatile mix of OpenAI, Worldcoin, and MrBeast. We deconstruct the high-risk, high-reward strategy behind its unique treasury.

Silo Pharma has navigated a critical headwind, regaining Nasdaq compliance. This move provides vital stability, allowing the firm to focus on its true test.

A $10,000 award to a future cyber defender is more than a press release. It's a look at how industry giants are tackling the global talent crisis.

Utah's Co-Diagnostics is transferring its AI-powered diagnostic platform to a Saudi JV. It's a bold move to crack a booming market and a critical test of its strategy.

Amid a spiraling insurance crisis, a new company called Stand is betting it can fix Florida's broken market by modeling risk down to the nail and rewarding resilience.

Intelinair's new AGMRI AI Agent promises instant answers to complex farm questions. Is this the tool that finally tames agricultural data for good?

Marius Silvasan's EY award highlights a deeper trend: how AI-powered fintechs are rewriting the rules of capital access for businesses of all sizes.